Teardown

Insurance / US-based global life & benefits · Deep dive

MetLife, Inc.

~$56B-market-cap, 158-year-old global life, benefits and retirement incumbent that survived its own ALICO + Travelers Life + Brighthouse-era empire-building, demutualized in 2000, now runs on an uncomfortable barbell — a sticky US Group Benefits book growing low-single-digits in a category that is itself maturing, a pension-risk-transfer engine whose growth is one rate cycle away from stalling, a ~$620B asset manager that is a mid-tier player in a world where Apollo and KKR raise private credit at $100B+ a year, and a Japan franchise half-earning in yen — all stapled together under a 'New Frontier' strategy that promises a 15–17% adjusted ROE through 2029 while a $100M+ funded insurtech (Nayya) sits between the insurer and the enrollee at open-enrollment time.

at risk

A 158-year-old global benefits incumbent whose Group Benefits moat is employer-switching friction (not product edge), whose PRT 'growth engine' depends on rising rates and will stall in a cutting cycle, whose MIM asset manager is sub-scale against Apollo/KKR-owned life insurers that structurally outbid it on institutional annuity liabilities, and that is already paying Nayya and other benefits-decision AI platforms to sit between it and the employee at open-enrollment time.

My take

HQ
200 Park Avenue, New York, NY
Founded
1868
Ownership
Public — NYSE: MET
Funding
Publicly traded — market cap ~$56B as of October 2026 (based on ~$83 share price and ~670M diluted shares outstanding, per MetLife 2Q 2026 release and consensus trading data)
Valuation
~$56B equity market cap; adjusted book value ex-AOCI per diluted share $57.19 at 30 June 2026, up 5% YoY (MetLife 2Q 2026 press release, 5 August 2026)
Revenue
FY2025 total revenue ~$73B; adjusted earnings ~$5.6B / adjusted EPS ~$8.20; Q2 2026 adjusted earnings $1.6B, adjusted EPS $2.30 (+5% YoY), Group Benefits adjusted earnings growth mid-single-digits, Asia adjusted earnings up double digits on constant-FX basis, RIS supported by pension-risk-transfer volume (MetLife 2Q 2026 press release, 5 August 2026)
Headcount
~45,000 (MetLife 2025 10-K, filed February 2026; roughly flat since 2023)
Screen
Public incumbent >$10B EV — ~$56B market cap, ~$73B FY2025 total revenue, >$680B total assets, ~$620B MIM AUM
Published
2026-10-22
Web
www.metlife.com
Elsewhere
LinkedIn · Crunchbase

Founders and leadership

  • Simeon Draper Co-founder (1868) of National Union Life and Limb Insurance Company — original New York State charter group

    New York State Republican politician and businessman; part of the small-group of New York civic figures (together with James R. Dow and others) that chartered National Union Life and Limb Insurance in 1868 to insure Civil War sailors and soldiers against wartime and workplace disability. The book pivoted away from war coverage within months of founding as the war ended and renamed itself Metropolitan Life Insurance Company the same year.

  • Joseph F. Knapp President 1871–1891 — the architect of the Industrial Insurance program that scaled MetLife to national dominance

    Took over a struggling New York life insurer in 1871 and imported from the UK the Industrial (burial) Insurance model — small weekly-premium life policies sold door-to-door to urban working-class households, with agents who literally collected cash at the kitchen table. By 1909 MetLife had put 20M of these policies in force and had become the largest life insurer in the United States. The business model Knapp built — direct-distribution agent force, mass-market policy sales, actuarial scale — is the DNA MetLife still trades on and the one it never figured out how to deprecate when distribution shifted to brokers and employer-sponsored plans in the 20th century.

  • Michel A. Khalaf President & CEO (since 1 May 2019); CEO & Chair of the Board (Chair added 2024)

    French-Lebanese-American executive; nearly four decades of insurance career almost entirely at American Life Insurance Company (ALICO) — the AIG international-life unit MetLife bought in 2010. Joined ALICO 1988 in Lebanon; ran MetLife EMEA (Europe, Middle East & Africa) 2011–2016, then MetLife US business + EMEA 2017–2019, then named CEO May 2019 succeeding Steve Kandarian. First non-US-based executive to run MetLife at the top. Oversaw the December 2024 'New Frontier' investor-day commitments (15–17% adjusted ROE, double-digit adjusted-EPS CAGR, $25B+ free cash flow through 2029) and the strategic pivot into private-credit asset management via Pine Street. Compensation: $23.3M total 2024 (MetLife DEF 14A, April 2026).

  • John D. McCallion Executive Vice President & CFO (since 2019); Head of MetLife Investment Management (since 2022)

    Rose through MetLife finance organization since 2003; prior CFO Asia and Treasurer. Named CFO 2019 under Khalaf. Dual-hatted as head of MetLife Investment Management since 2022 — unusual CFO scope reflecting the strategic importance management now places on the asset-management franchise. Signals that MIM is treated as a capital-allocation lever rather than a standalone business.

  • R. Glenn Hubbard Independent Lead Director (since 2024)

    Dean emeritus of Columbia Business School and former chair of the Council of Economic Advisers under George W. Bush (2001–2003). Long-tenured MetLife director; lead-director role codified in 2024 when Khalaf added Chair of the Board to his CEO title.

Snapshot

MetLife is the 158-year-old Metropolitan Life Insurance Company dressed up as a 2026 global diversified financial — NYSE: MET, ~$56B market cap, ~$73B FY2025 revenue, four operating pillars (US Group Benefits, RIS, Asia, LatAm), a ~$620B asset-management arm (MIM), and a legacy run-off book. CEO Michel Khalaf's December 2024 "New Frontier" plan targets a 15–17% adjusted ROE through 2029 — ambitious for a franchise whose Group Benefits persistency is already north of 90% (little more lock-in to extract), whose RIS growth engine depends on elevated rates and corporate derisking, and whose MIM AUM is dwarfed by the Apollo/KKR/Ares-owned life-insurer complex now outbidding MetLife for institutional annuity liabilities with cheaper private-credit yield. Q2 2026 adjusted earnings $1.6B / EPS $2.30 (+5% YoY) were respectable but not transformative (MetLife 2Q 2026 release, 5 August 2026).

Founding story

MetLife began in 1868 as National Union Life and Limb Insurance Company — a New York State mutual chartered to insure Civil War sailors and soldiers against disability, pivoting to civilian life within months and renaming to Metropolitan Life Insurance Company that same year. President from 1871 Joseph F. Knapp imported the UK Industrial Insurance model — weekly-premium burial policies sold door-to-door by commission agents collecting cash in person. By 1909 MetLife had 20M+ policies in force and was the largest US life insurer. The modern echoes remain: mass-market distribution, actuarial scale, and the industrial-era assumption that policyholders don't shop. MetLife mutualized in 1915, then demutualized in April 2000 (IPO at $14.25, ~$2.9B raised, ~$7B distributed to policyholders). Public MetLife then acquisition-swept: Travelers Life & Annuity from Citigroup for $11.8B (2005), then ALICO from a bailout-era AIG for $16.2B (November 2010) — the deal that converted MetLife from US-centric to global. The Khalaf CEO era came out of ALICO; he ran EMEA inside it before MetLife bought it.

How it works

MetLife underwrites long-dated insurance liabilities (group life, disability, dental, pensions, annuities, individual life) against a ~$500B+ general-account portfolio managed by MIM. Economics are three stacked spreads: underwriting margin, net investment spread, third-party fee spread. Group Benefits sits between MetLife's underwriting team and US employers (typically 500+ FTE), with brokers and consultants (Mercer, Marsh McLennan, Aon, Lockton) placing the business. Contracts renew every 1–3 years; employer-level persistency ~90–95% because switching at open-enrollment creates administrative friction (new cards, new claims systems, re-enrollment, dependents re-added) HR teams won't absorb without clear reason. RIS writes PRT (buy-outs, buy-ins), stable value, group annuities and structured settlements — one $5B PRT deal can move the segment's year. Asia runs out of Japan (bancassurance-dominant) with meaningful operations in Korea, China JV, Vietnam, Gulf. MIM manages the general account plus ~$150B of third-party assets, increasingly in private FI ($26B originated in 2025, MetLife, April 2026) following Pine Street.

Product and business overview

US Group Benefits. Largest segment by premium and brand footprint. Employer-sponsored group life, dental, vision, STD/LTD, voluntary benefits (accident, hospital indemnity, critical illness, MetLife Legal Plans), and the MetLife Pet line.

Retirement & Income Solutions (RIS). Pension risk transfer, institutional income annuities, stable value, structured settlements, longevity reinsurance. One-off PRT deals dominate the quarterly print.

Asia. Japan dominates (life, A&H, annuities, retail); also Korea, China JV, Vietnam, Gulf. Yen translation directly affects earnings; hedging doesn't erase structural FX exposure.

Latin America. Mexico and Chile largest; smaller books in Brazil, Argentina, Colombia, Uruguay. Includes AFP private pension in Chile.

EMEA. Smaller post-Brexit; Gulf, Turkey, Eastern Europe.

MetLife Holdings. Run-off retaining pre-Brighthouse variable annuities, long-term care, and in-force individual life MetLife did not spin.

MIM. ~$620B AUM. Public FI, private FI (post-Pine Street direct lending), real estate equity/debt, ag finance, structured credit. The strategic question is whether MIM can scale third-party AUM enough to move consolidated earnings — currently it does not.

Business model and pricing

Group Benefits books premium on an annual cycle; loss ratios ~85–90% group life, ~75–80% disability, ~70–75% dental, balance to admin and broker commissions. Expense ratios historically 15–20%. RIS prices PRT on an actuarial present-value basis (risk-free plus credit spread); MetLife's edge is scale and reputation for honouring long-dated commitments. Asia and LatAm are FX- and local-rate-sensitive; management reports constant-currency for a reason.

Pricing power is uneven. In Group Benefits, renewal rate actions run 3–6% a year on dental/disability, lower on life; brokers steer accounts away from aggressive renewals. In RIS, pricing is bid-based against Prudential, Athene, L&G, Pacific Life — operational trust is the differentiator more than price. Variable investment income (PE distributions, MIM LP interests) is reported separately; lower sequential VII was flagged on the Q2 2026 call as the reason adjusted EPS came in below the whisper (Benzinga, 6 August 2026).

Traction over time

Metric FY2022 FY2023 FY2024 FY2025 Q2 2026
Total revenue ~$70B ~$67B ~$71B ~$73B ~$18B Q
Adjusted earnings ~$6.3B ~$5.5B ~$5.8B ~$5.6B $1.6B Q
Adjusted EPS $7.70 $7.40 $8.10 $8.20 $2.30 Q
MIM AUM ~$590B ~$585B ~$600B ~$620B ~$625B
Adj BV ex-AOCI / share ~$52 ~$54 ~$55 ~$56.50 $57.19
Capital returned (div + bb) ~$5.0B ~$3.9B ~$4.4B ~$3.6B ~$900M Q

Adjusted earnings oscillated in the $5.5B–$6.3B band for four years — a mature franchise where organic growth and investment-income noise cancel. The 15–17% ROE target requires either a margin step-change or continued equity-base shrink through buybacks (buybacks the easier lever).

Market analysis

US employee-benefits total premium ~$200B annually (LIMRA, 2024), growing 3–5% a year — tracking wage growth more than any product cycle. US PRT volume reached ~$52B in 2024 and is expected to hit $100B annually (ai-CIO / planadviser, Oct 2025); the driver is corporate DB plans derisking as funded status rises on higher rates. Global life premium ~$3T (Swiss Re sigma, 2024). Private-credit AUM ~$1.7T in 2024 (Preqin), growing ~15% a year. The structural force on MetLife: insurance liabilities are migrating from traditional carrier balance sheets to private-credit-asset-manager-owned reinsurance vehicles — Athene (Apollo), Global Atlantic (KKR), Everlake (Blackstone), Resolution Life (Blackstone-majority) — which pair cheap retail-annuity liabilities with proprietary private-credit yield and systematically outbid traditional carriers on PRT and institutional annuity transactions.

Competitive intel

Prudential Financial (PRU) — ~$40B cap. Direct comp: PGIM bigger than MIM, Pru's Japan larger, Pru's Group Benefits smaller.

Athene (Apollo) — the single most important data point. Apollo-sourced private credit funds Athene's annuity liabilities at a lower cost than MetLife's general account; Athene has roughly doubled its PRT share since 2020 and routinely wins jumbo deals where MetLife and Pru were the duopoly. Pine Street is a credible answer, not an equalizer.

Guardian, MassMutual, Northwestern Mutual — US mutuals with pricing patience public MetLife cannot match without earnings volatility; Guardian the most direct Group Benefits peer.

Lincoln, Principal, Unum, Hartford — mid-cap US rivals across Group Benefits, retirement, specialty disability.

Nayya + Trellis + Dayforce + Workday + Rippling — benefits-decision and HR platforms layering on top of employers. Nayya $100M+ raised; MetLife owns equity plus a distribution partnership — the enrollment layer is becoming a value gate MetLife prefers to pay for rather than build.

Ethos, Ladder, Bestow, Fabric by Gerber — D2C digital term-life. MetLife exited retail term with Brighthouse but these shops normalize instant-issue consumer expectations that bleed back into group-life.

Legal & General, Pacific Life — growing PRT competitors.

History and evolution

  • 1868: National Union Life and Limb Insurance Co chartered; renamed Metropolitan Life.
  • 1871: Knapp president; Industrial Insurance imported from UK.
  • 1909: Largest US life insurer.
  • 1915: Mutualization formalised.
  • 5 April 2000: Demutualization + IPO at $14.25.
  • 1 July 2005: $11.8B Travelers Life & Annuity acquired from Citigroup.
  • 1 November 2010: $16.2B ALICO acquired from AIG.
  • 18 December 2014: FSOC designates MetLife a non-bank SIFI.
  • 30 March 2016: US District Court rescinds the SIFI designation.
  • 4 August 2017: Brighthouse Financial spinoff completes.
  • 18 January 2018: FSOC withdraws its SIFI appeal.
  • 1 May 2019: Michel Khalaf becomes CEO.
  • January 2022: MetLife-Nayya equity + distribution partnership.
  • Early 2024: MIM closes Pine Street Capital Partners acquisition.
  • 12 December 2024: "New Frontier" Investor Day — 15–17% ROE target through 2029.
  • 5 August 2026: Q2 2026 — $1.6B adjusted earnings, $2.30 adjusted EPS, +5% YoY.

What people say

The case for. Sell-side is constructive. JPMorgan raised its MET price target to $106 in July 2026 (MarketBeat, 21 July 2026). Analysts credit Khalaf with disciplined cost control, improving Asia constant-FX growth, and a credible New Frontier plan. S&P and Moody's maintain stable outlooks on Metropolitan Life Insurance Company at AA-/Aa3 (op-sub level); Fitch stable (BeInsure, 2024). Shareholders have received ~$30B of capital returns since 2017.

The complaints. Three themes. First, broker criticism: Group Benefits renewals are seen as price-aggressive without a service step-change, with trade press reporting Hartford and Guardian winning on mid-market service. Second, Glassdoor shows persistent layoffs, offshoring, pay-compression and RTO themes (one circulated review: "layoffs for next 3 years"; Glassdoor, 2024–2025). Third, Trustpilot and consumer forums carry sustained STD/LTD disability- and dental-denial complaints — the pattern that MetLife-administered plans deny first and ask later (Trustpilot, 2024–2026; echoed on BBB, Reddit, plan-sponsor forums).

Outlook: well positioned or at risk?

At-risk. The rubric requires two documented conditions; MetLife shows at least three, with a fourth plausible.

Condition 1 — organic growth tracking category, not beating it. Group Benefits premium growth 4–6% a year 2023–2025 vs a category growing 3–5% — in line, not winning. Adjusted earnings oscillated in the $5.5B–$6.3B band for four years. Asia constant-FX growth (~10%) is the one bright spot, much of it leaking on yen translation.

Condition 2 — margins protected by switching costs, not product edge. Group Benefits persistency 90–95% because employer switching is painful. In RIS the structural ROE edge over Athene is now reversed — the Apollo private-credit funding stack beats MetLife's general-account yield on jumbo PRT. Pru and MetLife, once a duopoly, routinely finish behind Athene on marquee deals.

Condition 3 — delivery model unchanged in 10+ years. Group Benefits enrollment, broker distribution, claims adjudication and dental-network administration are recognisable from the 2015 playbook. MyMetLife, Upwise, PlanSmart and the Nayya investment are overlays; the carrier-of-record decision and claims systems are the same mechanics.

Condition 4 — named funded challenger. Nayya has raised $100M+ and MetLife chose to invest-and-partner rather than compete. If Nayya moves from decision support to carrier recommendation and switching, MetLife's persistency moat shrinks. Apollo/Athene is the asset-side funded challenger that matters most.

The defensive counter is real — cash-generative, ~3% dividend, aggressive buyback, globally diversified book. But those attributes compound slowly, they don't extend the lead. Well-positioned per the rubric requires a specific protection that compounds. MetLife's genuine protections (switching friction, Japan scale, PRT trust) are durable but not compounding, and the one explicitly underway response (MIM private credit via Pine Street) is small against the Apollo scale it is responding to.

How to attack it

A seed-stage attacker cannot replace MetLife at the risk-pool level. The attackable surfaces are at the distribution, enrollment and claims layers between MetLife and the employee.

The benefits-decision broker-of-record wedge. Nayya has shown that an AI-driven benefits-decision tool can insert itself into open enrollment at scale, and MetLife chose partnership over conflict. The next-generation attacker goes further: a platform that, after walking the employee through election, also arbitrages across carriers (MetLife, Guardian, Unum, Hartford, Principal) and takes commission from the winning carrier. Broker-of-record with AI underwriting on top. Employers pay nothing; employees get better advice; carriers compete on price; MetLife loses the opaque pricing/renewal premium. Nayya, Trellis and Dayforce Wallet are each one strategic step away; Rippling and Workday are a software-platform acquisition away.

The AI claims-adjudication wedge. STD/LTD and dental claims are MetLife's top complaint categories. A SaaS vendor offering claim-process-as-a-service to employers (SLA on denial-reversal rates, LLM-driven appeal letters, provider-dispute automation) sits on top of MetLife's claims friction and forces MetLife to pay for better outcomes.

The private-credit-funded reinsurer wedge. Hardest to seed-stage but biggest structural wedge: a new life insurer or reinsurer with a private-credit asset-manager parent (the Apollo/Athene template) outbids MetLife on PRT and institutional annuities. Resolution Life, Global Atlantic, Everlake, Fortitude Re, Haymarket Re already exist. Capital-gated but the economics are proven.

Weaknesses to exploit. (1) Group Benefits margin visibility is poor — brokers can arbitrage carrier renewals if given data. (2) MIM is sub-scale against Apollo/KKR/Ares; Pine Street is a start, not an answer. (3) VII volatility makes earnings quality worse than headline. (4) Dental and disability claim friction is a repeat complaint pattern. (5) Glassdoor layoffs/offshoring/pay-compression themes suggest institutional knowledge leaving faster than it is being rebuilt.

Adjacent-segment play

MetLife's core — long-duration insurance liabilities held against a general-account investment portfolio — does not generalise easily down-market or into adjacent risk pools, and that is both the moat and the problem.

Down-market SMB benefits. MetLife's cost base is calibrated for giant-case employers. The sub-500-FTE segment is served by Principal, Hartford, and insurtechs like Rippling and Gusto. Attacker opportunity: a self-insured-captive-plus-reinsurer stack sold to 50–500 FTE employers with a software-first enrollment and claims flow. Decent, Centivo and Nava Benefits are seeded occupants.

Up-market asset management. MIM at ~$620B is squeezed between the full-stack asset managers (BlackRock $12T+, PIMCO) and the private-credit cohort (Apollo, Ares, KKR). The attacker opportunity is a founder-led private-credit originator targeting liability-driven asset management as a service.

Adjacent geography — LatAm consumer life. MetLife has strong Mexico and Chile positions. A D2C digital life insurer in Mexico (where MetLife is strong but legacy-distributed) is attackable; Betterfly (Chile), Clip (Mexico, embedded) and local insurtech MGAs are positioned.

Adjacent value prop — portable benefits for distributed workforces. Freelancer and gig portable benefits is a mapped segment (Catch died, Trellis still exists). Not core but brand-adjacent and could be a growth adjacency.

The honest read: MetLife's underwriting-at-scale is a defensive asset that does not travel well. The attackable surfaces are above (enrollment/decision layer) and beside (private-credit asset management). Neither is unoccupied, both are under-scaled relative to the opportunity.

Sources and further reading

Capital history

DateRoundAmountValuationLead(s)
1868 National Union Life and Limb Insurance Company chartered in New York State to insure Civil War sailors and soldiers against disability; pivots to civilian life insurance within months of founding and renames to Metropolitan Life Insurance Company (same year) n/a — mutual company bootstrap n/a New York State charter / Simeon Draper and co-founders
1871 Joseph F. Knapp becomes president, imports UK Industrial (burial) Insurance model to the US n/a — operational n/a n/a
1909 MetLife becomes the largest life insurer in the United States by policies in force (~20M Industrial Insurance policies) n/a n/a n/a
1915 Formal mutualization — Metropolitan Life Insurance Company becomes a mutual company owned by its policyholders n/a n/a n/a
2000-04-05 IPO on NYSE under ticker MET following full demutualization. Priced at $14.25/share, raised ~$2.9B (then one of the largest US IPOs); shares distributed to policyholders of record ~$2.9B IPO (plus ~$7B distributed to policyholders in cash and stock) ~$11B initial market cap Goldman Sachs / Credit Suisse First Boston
2005-07-01 MetLife completes acquisition of Travelers Life & Annuity from Citigroup — immediately scales up MetLife's annuity and retirement businesses $11.8B (cash + stock) n/a MetLife / Citigroup
2010-11-01 MetLife completes acquisition of American Life Insurance Company (ALICO) from AIG — buys AIG's international life unit (dominant in Japan, strong in LatAm, EMEA) and the biggest single transformation of the modern era. Converts MetLife from a mostly-US insurer into a global multi-regional one $16.2B (cash + stock + preferred securities) n/a MetLife / AIG
2014-12-18 FSOC designates MetLife a non-bank Systemically Important Financial Institution (SIFI) — only insurer other than AIG and Prudential given the designation n/a — regulatory n/a FSOC
2016-01-12 MetLife announces plan to separate its US retail business via spinoff (eventually Brighthouse) partly to escape the SIFI regime n/a — strategic n/a MetLife / board
2016-03-30 US District Court (Judge Rosemary Collyer) rescinds FSOC's SIFI designation of MetLife — the first and only successful SIFI legal challenge n/a — regulatory win n/a US District Court DC
2017-08-04 Brighthouse Financial completes spinoff — distributed to MetLife shareholders, begins trading on Nasdaq (BHF). MetLife sheds the US retail variable-annuity / universal-life legacy book worth ~$240B of liabilities at spin n/a — spinoff distribution ~$6B initial Brighthouse market cap MetLife board
2018-01-18 FSOC voluntarily withdraws its appeal of the Collyer ruling — MetLife formally and permanently de-designated as a SIFI n/a — regulatory n/a FSOC
2019-05-01 Michel Khalaf becomes CEO; Steve Kandarian retires after 8-year CEO tenure n/a — leadership n/a MetLife board
2022-01 MetLife announces equity investment in Nayya alongside enterprise distribution partnership — MetLife begins embedding Nayya's AI-driven benefits-decision tool into enrollment flows for employer customers undisclosed strategic investment (Nayya Series B total ~$36M) ~$180M (Nayya post-money) ICONIQ Growth (lead); MetLife, Guardian participate
2022-10 Nayya closes Series C of ~$55M bringing total raised to $100M+; MetLife maintains partner-and-investor relationship ~$55M Series C ~$485M Transformation Capital
2023-12 to 2024-01 MetLife Investment Management announces acquisition of Pine Street Capital Partners (private-credit direct lending) — closes early 2024; MIM steps materially into the private-credit race undisclosed n/a MIM / Pine Street
2024-12-12 'New Frontier' Investor Day — Khalaf announces 5-year financial commitments: 15–17% adjusted ROE, double-digit adjusted-EPS CAGR, $25B+ free cash flow through 2029, aggressive growth plans for MIM, Group Benefits, Asia and Latin America n/a — strategic n/a MetLife
2025-FY (year ended 31 December 2025) FY2025: total revenue ~$73B; adjusted earnings ~$5.6B; adjusted EPS ~$8.20; MIM AUM ~$620B; capital returned ~$3.6B dividends + buybacks n/a n/a n/a
2026-Q2 (quarter ended 30 June 2026) Q2 2026 results — adjusted earnings $1.6B; adjusted EPS $2.30 (+5% YoY); Group Benefits mid-single-digit earnings growth; Asia double-digit earnings growth on constant-FX; variable investment income lower sequentially; adjusted book value ex-AOCI per diluted share $57.19 (MetLife press release, 5 August 2026) n/a n/a n/a

Investors / owners: Public float. Top institutional holders (2026, per 13F filings): Vanguard (~9.5%), BlackRock (~8%), State Street (~5%), Capital Group / Capital World Investors, Massachusetts Financial Services (MFS), T. Rowe Price, Wellington, JPMorgan Asset Management, Dodge & Cox, Berkshire Hathaway: not a current holder of material MET position; Buffett has publicly favoured property-casualty over traditional life, No single activist position has gone public since the 2017 Brighthouse spinoff cycle

Competitive set

  • Prudential Financial (PRU) — NYSE: PRU. ~$40B market cap. Direct peer across all four core lines — US group benefits, pension risk transfer, Japan life, asset management (PGIM). PRU and MET are the two most natural head-to-head comps. Pru has a larger Japan franchise and PGIM has more AUM; MetLife has a stronger Group Benefits franchise and larger pension-risk-transfer book over the past five years.
  • The Guardian Life Insurance Company of America — Private mutual. Direct US group benefits competitor; strong dental, disability and employer-sponsored life positions. Mutual structure allows pricing patience MetLife (as a public co) cannot match without earnings volatility.
  • Lincoln Financial Group (LNC) — NYSE: LNC. ~$5–6B market cap. US group benefits + annuities + retirement; smaller and still working through its own derisking cycle but structurally overlaps MET in employer-sponsored life/disability/dental and institutional annuities.
  • Principal Financial Group (PFG) — NYSE: PFG. ~$17B market cap. Specialist in retirement/401(k) + specialty benefits for SMB; attacks the small-to-mid employer segment MetLife is less dominant in.
  • Unum Group (UNM) — NYSE: UNM. ~$10B market cap. The disability specialist; direct competitor in group long-term disability where MetLife has historically been top-3. Unum is the price leader when it wants to be and has been taking share in supplemental-health.
  • The Hartford Financial Services (HIG) — NYSE: HIG. Group benefits platform built from the 2017 Aetna group acquisition — targets the mid-market employer segment with better service economics than MetLife's giant-case bias.
  • Equitable Holdings (EQH) — NYSE: EQH. ~$15B market cap. US retirement & annuities + AllianceBernstein; overlaps MET in individual annuities, group retirement and asset management (AB vs MIM).
  • MassMutual — Private mutual. Direct peer in life + annuities + group benefits; owns Barings asset manager. Mutual structure again provides pricing latitude.
  • Athene (Apollo subsidiary) — Private — operating subsidiary of Apollo Global (NYSE: APO). The dominant PRT writer. Athene has roughly doubled its PRT share since 2020 by pairing cheap retail-fixed-annuity funding with Apollo-sourced private-credit yield. Fundamentally competes against MetLife's RIS segment, with a cost-of-funds advantage MIM cannot structurally match.
  • Legal & General (LGEN.L) — LSE: LGEN. ~£17B market cap. Dominant UK PRT writer and a growing US PRT competitor, often partnering with MetLife on jumbo transactions but increasingly going head-to-head on US cases.
  • Pacific Life — Private mutual holding; growing US PRT competitor and life/annuity underwriter.
  • Nayya — Private insurtech. Series C $55M in October 2022; cumulative >$100M raised across Series B/C and strategic rounds. AI-driven benefits-decision tool for enrollees; sits on top of employer open-enrollment and makes carrier-level choices. MetLife is a strategic investor and distribution partner — a telling admission that the enrollment-layer software is becoming a value gate MetLife prefers to pay-to-sit-inside rather than build or compete with. If Nayya ever moves from decision-support to carrier-recommendation-and-switching, MetLife's Group Benefits persistency moat shrinks.
  • Ethos / Ladder / Fabric by Gerber Life / Haven Life (acquired, now wound down) / Bestow — Direct-to-consumer digital-life insurtechs attacking the simplified-issue term-life market. ~$100M+ raised each (Ethos $400M+, Ladder $100M+). Each uses algorithmic underwriting with no medical exam. They attack the individual-life pond MetLife has been retreating from since Brighthouse, but normalize instant-issue consumer expectations that bleed back into the group-life product.
  • Trellis / Dayforce Benefits / Workday / Rippling — HR/benefits platforms layering over the employer. Rippling and Workday own the employee-master-data; Dayforce (Ceridian) and Trellis build benefits-decision and claims-concierge features. The strategic risk is that these platforms become the broker-of-record for the employee and compress the insurer brand to utility status — the same disintermediation playbook that fintechs ran against card issuers.
  • Insurtech MGA cohort — Nayya partners, Pie Insurance, Coalition, etc. — Not direct carriers to MetLife but structural counterparties — any platform that aggregates benefits selection, claims adjudication or small-business insurance decisions compresses insurer margins at the distribution layer.
  • Apollo / KKR / Ares / Blackstone (via owned life insurers Athene / Global Atlantic / Everlake / Resolution Life) — The private-credit-asset-manager-owned life insurer cohort is the single most important structural threat to MetLife. These vehicles raise cheap retail-annuity liabilities, invest them into proprietary private credit originated by their asset-manager parent, and consistently outbid MetLife on PRT and institutional annuity transactions. MIM's ~$620B AUM is dwarfed by Apollo (~$750B) and the originating economics are structurally inferior unless MIM can scale third-party and private-credit origination fast.